Gossamer Bio appoints Bob Smith as Chief Commercial Officer

Gossamer Bio announced the appointment of Bob Smith as its Chief Commercial Officer. “We are proud to welcome Bob Smith to the Gossamer team and his 30 years of expertise at this critical time in our company’s history,” said Faheem Hasnain, Chairman, Co-Founder and CEO of Gossamer Bio. “With Bob’s arrival, Gossamer is well-positioned to transition itself from a pre-commercial, clinical-stage biotechnology company to a fully integrated commercial organization focused on bringing seralutinib to patients with pulmonary hypertension. Given his distinguished experience as a senior commercial leader at both Merck and Actelion, and having launched significant PAH brands, we are confident that Bob is the best person for this key role, and we appreciate the confidence that such an accomplished commercial professional has shown in seralutinib by joining Gossamer Bio.”